Intermittent hypoxia-related alterations in vascular structure and function: a systematic review and meta-analysis of rodent data.

Background: Obstructive sleep apnoea and the related intermittent hypoxia (IH) are widely recognised as risk factors for incident cardiovascular diseases. Numerous studies support the deleterious vascular impact of IH in rodents but an overall interpretation is challenging owing to heterogeneity in rodent species investigated and the severity and duration of IH exposure. To clarify this major issue, we conducted a systematic review and meta-analysis to quantify the impact of IH on systemic artery structure and function depending on the different IH exposure designs.
Methods: We searched PubMed, Embase and Web of Science, and included 125 articles in a meta-analysis, among them 112 using wild-type rodents and 13 using apolipoprotein E knockout (ApoE ^-/- ) mice. We used the standardised mean difference (SMD) to compare results between studies.
Results: IH significantly increased mean arterial pressure (+13.90 (95% CI 11.88-15.92) mmHg), and systolic and diastolic blood pressure. Meta-regressions showed that mean arterial pressure change was associated with strain and year of publication. IH altered vasodilation in males but not in females and increased endothelin-1-induced but not phenylephrine-induced vasoconstriction. Intima-media thickness significantly increased upon IH exposure (SMD 1.10 (95% CI 0.58-1.62); absolute values +5.23 (2.81-7.84) µm). This increase was observed in mice but not in rats and was negatively associated with age. Finally, IH increased atherosclerotic plaque size in ApoE ^-/- mice (SMD 1.08 (95% CI 0.80-1.37)).
Conclusions: Our meta-analysis established that IH, independently of other confounders, has a strong effect on vascular structure and physiology. Our findings support the interest of identifying and treating sleep apnoea in routine cardiology practice.
Competing Interests: Conflict of interest: O. Harki has nothing to disclose. Conflict of interest: Q. Boete has nothing to disclose. Conflict of interest: J-L. Pépin has nothing to disclose. Conflict of interest: C Arnaud has nothing to disclose. Conflict of interest: E. Belaidi has nothing to disclose. Conflict of interest: G. Faury has nothing to disclose. Conflict of interest: C. Khouri has nothing to disclose. Conflict of interest: A. Briançon-Marjollet has nothing to disclose.
(Copyright ©The authors 2022. For reproduction rights and permissions contact permissions@ersnet.org.)